[Economic and clinical impact of a controlled sedation procedure in an intensive care unit].
OBJECTIVE
Since the last consensus conducted by Sfar/SRLF, the use of protocol for sedation became the reference in our ICUs. Decrease in length of stay and length of mechanical ventilation with used of these protocols have been already described. We would like to investigate the economic impact associated.


METHODS
Using the PMSI data, we studied retrospectively, the economic effect, one year before and one year after protocol implementation in our ICU.


METHODS
The economic evaluation compared the cost of sedation but also the cost of mechanical ventilation and length of stay in ICU.


RESULTS
Characteristic and number of patients were equivalent during the two years. We described a significant decrease in length of mechanical ventilation (8.8 vs. 8.4; p<0.05) but not in length of stay (11.4 vs. 11.7; NS) between the two periods. We described a decrease of sedation cost of 11 412 euros and a decrease of mechanical ventilation cost of 27 360 Euros between the two years.


CONCLUSIONS
We confirm in this study that use of sedation protocol in ICU is associated with a clinical impact but also with an economic effect.
Réanimation médicochirurgicale, hôpital Saint-Roch, CHU de Nice, 4, rue Pierre-Dévoluy, 06000 Nice, France. quintard.h@chu-nice.fr
H
H
Quintard
L
L
Tran-Marsalla
C
C
Esquirole
C
C
Ichai
D000328:Adult; D000368:Aged; D002985:Clinical Protocols; D016292:Procedural Sedation / Q000191:economics* / Q000379:methods / Q000706:statistics & numerical data; D003365:Costs and Cost Analysis; D003422:Critical Care / Q000191:economics* / Q000379:methods; D016208:Databases, Factual; D005260:Female; D005283:Fentanyl / Q000191:economics / Q000627:therapeutic use; D005602:France; D006801:Humans; D006993:Hypnotics and Sedatives / Q000191:economics / Q000627:therapeutic use; D007362:Intensive Care Units; D007902:Length of Stay; D008171:Lung Diseases / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008874:Midazolam / Q000191:economics / Q000627:therapeutic use; D008875:Middle Aged; D010880:Piperidines / Q000191:economics / Q000627:therapeutic use; D000077208:Remifentanil; D012121:Respiration, Artificial / Q000191:economics / Q000379:methods; D012189:Retrospective Studies
D006993:Hypnotics and Sedatives; D010880:Piperidines; D000077208:Remifentanil; D008874:Midazolam; D005283:Fentanyl